We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $2.04B
1-Year Est. Return 94.26%
This Fund
S&P 500
This Quarter Est. Return
+71.62%
1 Year Est. Return
+94.26%
3 Year Est. Return
+310.51%
5 Year Est. Return
+306.13%
10 Year Est. Return
+3,783.92%
AUM
$1.25B
AUM Growth
+$397M
Cap. Flow
+$4.29M
Cap. Flow %
0.34%
Top 10 Hldgs %
51.06%
Holding
171
New
21
Increased
21
Reduced
27
Closed
26

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.02%
2 Communication Services 20.29%
3 Consumer Discretionary 18.9%
4 Healthcare 18.2%
5 Financials 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPLI
1
People Inc
PPLI
$2.82B
$166M 13.28%
2,870,724
+1,692,611
+144% +$75.2M
CVNA icon
2
Carvana
CVNA
$53.1B
$165M 13.21%
6,867,115
-450,000
-6% -$8.43M
CDLX icon
3
Cardlytics
CDLX
$23.6M
$59.9M 4.8%
85,661
-1,000
-1% -$577K
NKLA
4
PUT
DELISTED
Nikola Corporation Common Stock
NKLA
$58.7M 4.7%
+28,977
New +$27.9M
EMB icon
5
PUT
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.5B
$43.7M 3.5%
+400,000
New +$41.4M
AMZN icon
6
Amazon
AMZN
$2.72T
$33.1M 2.65%
240,000
COF icon
7
Capital One
COF
$130B
$30.8M 2.46%
491,617
-64,200
-12% -$4M
PCG icon
8
PG&E
PCG
$31.7B
$28.2M 2.26%
3,183,216
+3,183,116
+3,183,116% +$34.7M
TSLA icon
9
CALL
Tesla
TSLA
$1.46T
$27M 2.16%
375,000
DEO icon
10
Diageo
DEO
$47.9B
$25.5M 2.04%
190,000
+15,000
+9% +$2.06M
NKLA
11
CALL
DELISTED
Nikola Corporation Common Stock
NKLA
$25.3M 2.03%
+12,503
New +$12.1M
VTR icon
12
PUT
Ventas
VTR
$45.7B
$22M 1.76%
600,000
QURE icon
13
uniQure
QURE
$3.21B
$21.6M 1.73%
480,000
-10,000
-2% -$591K
EIGR
14
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$20.7M 1.66%
71,895
+3,895
+6% +$1.15M
ADNT icon
15
Adient
ADNT
$1.42B
$19.8M 1.58%
1,203,588
-50,000
-4% -$760K
GM icon
16
CALL
General Motors
GM
$74.3B
$19M 1.52%
750,000
GOTU icon
17
PUT
Gaotu Techedu
GOTU
$510M
$18M 1.44%
+300,000
New +$11.9M
MO icon
18
Altria Group
MO
$113B
$17.8M 1.43%
453,860
-70,000
-13% -$2.73M
ENVA icon
19
Enova International
ENVA
$5.57B
$17.1M 1.37%
1,148,058
+50,119
+5% +$697K
AFMD
20
DELISTED
Affimed
AFMD
$16.8M 1.35%
365,000
+215,000
+143% +$5.98M
IMTX icon
21
Immatics
IMTX
$1.42B
$16.5M 1.32%
1,050,000
+50,000
+5% +$614K
ALNY icon
22
Alnylam Pharmaceuticals
ALNY
$34.2B
$15.6M 1.24%
105,000
-65,000
-38% -$8.76M
B
23
Barrick Mining
B
$73.7B
$15.1M 1.21%
561,477
+50,000
+10% +$1.25M
SNDX icon
24
Syndax Pharmaceuticals
SNDX
$1.78B
$15.1M 1.21%
1,016,371
+83,333
+9% +$1.27M
ARDX icon
25
Ardelyx
ARDX
$963M
$14.9M 1.19%
2,154,184

Similar funds

683 Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, 683 Capital Management held 171 positions worth $1.25B, up 47% from $853M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

683 Capital Management's Q2 2020 filing shows 21 new, 21 increased, 27 reduced and 26 closed positions. Its largest new stake was ARYA Sciences Acquisition Corp II Unit: 700,000 shares worth $8.12M. The largest sale was Wayfair, an estimated $29.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • 683 Capital Management's largest Q2 2020 buy was ARYA Sciences Acquisition Corp II Unit: 700,000 shares worth $8.12M.
  • 683 Capital Management added most to People Inc in Q2 2020, an estimated $75.2M increase.
  • 683 Capital Management's biggest Q2 2020 reduction was Wayfair, cutting an estimated $29.2M.
  • 683 Capital Management fully exited Nikola Corporation Common Stock in Q2 2020, selling an estimated $7.23M.
  • 683 Capital Management's ten largest holdings make up 51% of its $1.25B portfolio in Q2 2020.
  • 683 Capital Management opened 21 new positions and closed 26 in Q2 2020.
  • 683 Capital Management's portfolio value rose 47% quarter-over-quarter to $1.25B.

Based on 683 Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.